Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 101
|
ETA2024
|
Next issue
46th Annual Meeting of the European Thyroid Association (ETA) 2024
All volumes
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstracts
Abstract Book
Contents
Oral Presentations
Oral Session 1: Topic Highlights
Birth defects in children born to mothers with thyroid disease: biochemical assessment in 20,399 pregnancies substantiates that thyroid function and thyroid autoimmunity are not the causal links
ea0101op-01-01
Reprogramming myeloid bone marrow progenitors in non-medullary thyroid cancer using trained immunity
ea0101op-01-02
Novel Tr-[beta] selective agonist TG68 promotes anti-inflammatory, lipid-lowering and anxiolytic effects
ea0101op-01-03
Unveiling severe adverse events of antithyroid drugs in patients with graves' disease; a real-world multicenter cohort study
ea0101op-01-04
Dabrafenib and trametinib in BRAFV600E anaplastic thyroid cancers: an italian real-word series
ea0101op-01-05
Cut&tag reveals distinct TRA2-specific DNA binding profiles in HIPSC-derived cardiomyocytes
ea0101op-01-06
Oral Session 2: Thyroid hormone action in the brain
Thyroid hormone transporters MCT8 and OATP1C1 exhibit cell-autonomous functions within the oligodendroglia cell lineage in the mouse CNS
ea0101op-02-01
Gestational hypothyroxinemia in dehal1ko mice: discordant T3-dependent gene expression in brain regions and autistic-like phenotype in the offspring
ea0101op-02-02
Thyroid hormone transporters MCT8 and OATP1C1 are required for proper angiogenesis in the mouse CNS
ea0101op-02-03
Exploring the role of TR[beta] in the process of cortical neuron differentiation
ea0101op-02-04
A Novel MCT8 point-mutant mouse model shows effectiveness of phenylbutyrate treatment
ea0101op-02-05
Oral Session 3: Young Investigators/Clinical and Translational
Impact of reclassification of oncocytic and follicular thyroid carcinoma by the 2022 who classification
ea0101op-03-01
Impact of physical activity and its maintenance in the efficacy and safety of tyrosine kinase inhibitors in advanced thyroid carcinoma patients
ea0101op-03-02
Effects of tocilizumab treatment in corticosteroid-resistant graves' orbitopathy
ea0101op-03-03
T3 analogue triiodothyroacetic acid (TRIAC) treatment and survival in MCT8 deficiency: an international real-world cohort study
ea0101op-03-04
Predictors of disease progression in patients with suspicious lymph nodes after initial treatment for thyroid carcinoma
ea0101op-03-05
The association of maternal thyroid function with offspring iq and brain morphology: persistency into early adolescence and relevance of tpoab positivity
ea0101op-03-06
Oral Session 4: Young Investigators/Basic
Identifying novel DIO1 inhibitors to modulate hepatic T3 availability in context of non-alcoholic fatty liver disease
ea0101op-04-01
Thyroid hormone transporters MCT8/OATP1C1 deficient mice exhibit increased seizure susceptibility together with an imbalanced hippocampal neurotransmission
ea0101op-04-02
The role of type 3 deiodinase in a human model for early brain development
ea0101op-04-03
Blood-brain barrier leakage and neurovascular unit ultrastructural alterations as new pathophysiological mechanisms for MCT8 deficiency
ea0101op-04-04
Investigating the role of DICER1 in thyroid tumorigenesis
ea0101op-04-05
Single cell analysis of a thyroid cancer cell line resistant to lenvatinib
ea0101op-04-06
Oral Session 5: Thyroid dysfunction-1
A novel point of care device accurately and rapidely measures thyrotropin in capillary blood
ea0101op-05-01
Exploring the relationship between TSH levels and cardiovascular health in euthyroid individuals: insights from elsa-brasil study
ea0101op-05-02
Cardiovascular risk and mortality in a large italian cohort of patients with resistance to thyroid hormone [beta] (RTH[beta])
ea0101op-05-03
The quality of life impact of weight gain in treated hyperthyroidism
ea0101op-05-04
Effect of the T3 analogue triac on patient-centered outcome measures in patients with MCT8 deficiency: post-hoc analysis of the international triac trial I
ea0101op-05-05
Systematic review of mortality and long-term major cardiovascular events (MACE) following different treatment approaches for hyperthyroidism
ea0101op-05-06
Long-term outcomes of LT4/LT3 combination treatment for persistent hypothyroid symptoms
ea0101op-05-07
Oral Session 6: Translational thyroid cancer research
The role of TPO antibodies in immune escape of aggressive tumors of thyroid follicular cells
ea0101op-06-01
Clinical utility of circulating tumoral dna analysis by multi-gene ngs panels in therapy monitoring of advanced sporadic medullary thyroid carcinoma patients
ea0101op-06-02
Digoxin treatment does not reinduce uptake of radioiodine in metastatic radioiodine refractory non-medullary thyroid carcinoma
ea0101op-06-03
Clinically relevant germline genetic variants and somatic fusions underlying paediatric thyroid cancer risk and aggressiveness
ea0101op-06-04
Molecular profiling of low-risk papillary thyroid carcinomas (MPTC) on active surveillance
ea0101op-06-05
Clinical implications of the gut microbiome in anaplastic thyroid cancer
ea0101op-06-06
Performance of the mir-thype new version algorithm in classification of thyroid indeterminate nodules: latin american multicenter validation study
ea0101op-06-07
Oral Session 7: Thyroid hormone mechanisms in diseases
The protective role of androgen on experimental graves'hyperthyroidism in balb/c mice
ea0101op-07-01
Abrogation of hepatic tr[beta] action attenuates acetaminophen-induced acute liver injury in mice
ea0101op-07-02
Characteristics of hyaluronan metabolism during myofibroblast differentiation in orbital fibroblasts
ea0101op-07-03
Absence of cholesterol gallstone formation in male C57BL/6 mice by abrogation of hepatic thyroid hormone action
ea0101op-07-04
Altered skull and bone morphology in hyperthyroid knock-in mice with TSHR M453T and D633H mutations
ea0101op-07-05
Oral Session 8: Pregnancy
Clinically relevant differences between routinely used immunoassays for thyroid function testing: a danish study of non-pregnant and pregnant adults
ea0101op-08-01
Stimulating TSH-receptor antibodies in early pregnancy using the turbo TSI bioassay: a study of 3,028 pregnant women in the north denmark region
ea0101op-08-02
Detailed morphological phenotyping of maternal thyroid function and offspring brain development: a vertex-wise approach including assessment of gyrification
ea0101op-08-03
Fluid intelligence evaluation through raven's progressive matrices in adult patients with congenital hypothyroidism detected by neonatal screening
ea0101op-08-04
Maternal thyroid function and biochemical markers of placental function in early pregnancy
ea0101op-08-05
Oral Session 9: Basic thyroid cancer research
Epigenetic deregulation and dedifferentiation in thyroid cancer
ea0101op-09-01
TP53 mutations associate with poor response to lenvatinib treatment for advanced thyroid cancer
ea0101op-09-02
Role of the oncogene UHRF1 in thyroid cancer differentiation, progression and response to lenvatinib
ea0101op-09-03
Tumour heterogeneity and evolution in advanced thyroid cancer through multiregion and longitudinal sampling
ea0101op-09-04
Tracing the molecular route to progression in defective mirna biogenesis benign vs malignant thyroid lesions
ea0101op-09-05
Oral Session 10: Thyroid dysfunction-2
Effect of smoking status on TSH receptor antibody (TRAB) levels following treatment for graves' disease
ea0101op-10-01
Towards personalized TSH reference ranges: a genetic and population-based approach in three independent cohorts
ea0101op-10-02
Compensatory rise in TSH when blocking sympathetic activity in cold exposed hunters in east greenland
ea0101op-10-03
The relation between circulating free thyroxine (FT4) and thyroid stimulating hormone (TSH) levels is very different in people taking levothyroxine vs those who are on no thyroid hormone replacement
ea0101op-10-04
Whole-brain computational anatomy in graves' disease: morphometric imprint of pathology and recovery
ea0101op-10-05
Oral Session 11: Molecular Thyroidology
Thyroid Hormone Receptor A1 is a novel regulator of P53 functions
ea0101op-11-01
KLHL14 and its anti-sense lncrna are involved in thyroid cells differentiation
ea0101op-11-02
Molecular mechanisms of triac in the treatment of resistance to thyroid hormone beta (RTH[beta])
ea0101op-11-03
Systematic screening of natural compounds: impacts on thyroid transcriptional activity and NRF1/NRF2 activation
ea0101op-11-04
Perinatal exposure to tbbpa interferes with the establishment of the thyroid axis at young age and the ability to cope with metabolic challenges in adulthood
ea0101op-11-05
Unraveling the genetic landscape of hypothyroidism: insights from a multi-ancestry GWAS meta-analysis
ea0101op-11-06
Hepatocyte-specific DIO3 knockout influences energy metabolism in female mice
ea0101op-11-07
Oral Session 12: Clinical thyroid cancer research
Predictive factors of persistent disease in a large cohort of pediatric patients with differentiated thyroid carcinoma
ea0101op-12-01
Insights from active surveillance: patterns of papillary thyroid carcinoma growth and conversion surgery outcomes
ea0101op-12-02
Patients with medullary thyroid carcinoma and long term treatment with vandetanib: a study from the endocan -tuthyref network
ea0101op-12-03
Pronosthyc: prognostic factors in radioiodine refractory differentiated thyroid cancer with distant metastases, a multicentric study from a french network of referral centers
ea0101op-12-04
Real world outcomes of patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated in 1l with lenvatinib 24 mg: an international multicenter real-world study in europe and canada
ea0101op-12-05
Insight of prospective nora (no radioiodine ablation) study in patients with differentiated thyroid carcinoma (DTC)
ea0101op-12-06
Randomized clinical trial of prophylactic central neck dissection in 2100 papillary thyroid carcinoma patients with clinically negative central neck metastasis: an interim analysis of a single institution
ea0101op-12-07
Oral Session 13: TED
VRDN-003, a full antagonist antibody to IGF-1R for thyroid eye disease (TED): phase 1 results show potential for subcutaneous administration
ea0101op-13-01
Response to teprotumumab is independent of race, ethnicity, and age
ea0101op-13-02
Abstract withdrawn
ea0101op-13-03
Target-tissue immunophenotyping of patients with thyroid eye disease before and after therapy with steroids, tocilizumab and rituximab
ea0101op-13-04
Efficacy of teprotumumab on medical and surgical resistant don
ea0101op-13-05
Prognostic factors and outcomes of intravenous glucocorticoid pulse therapy in moderate-to-severe thyroid eye disease
ea0101op-13-06
Long-term outcome of graves' orbitopathy following treatment with sirolimus (RAPAMYCIN)
ea0101op-13-07
Poster Presentations
Autoimmunity
Modelling of mechanical stimuli through piezo1 receptor activation and its effect on adipogenic differentiation of orbital fibroblasts
ea0101ps1-01-01
Thyrotropin receptors stimulating antibodies in pediatric patients with graves' disease using ultra-rapid turbo bioassay
ea0101ps1-01-02
Specific patterns of orbital-resident B and T lymphocytes are related to different clinical presentations of thyroid eye disease
ea0101ps1-01-03
Production of chemerin by orbital fibroblasts during myofibroblast and adipocyte differentiation
ea0101ps1-01-04
Interplay between thyroid hormones, liver gene expression, and thyroid eye disease in a murine model of graves' disease
ea0101ps1-01-05
Phenotypical and functional flow cytometry study of natural killer cells in graves' disease
ea0101ps1-01-06
The prevelence of autoimmune thyroidit and the role of regulatory cells in its pathogenesis
ea0101ps1-01-07
In vivo
effect of maraviroc, a CCR5 receptor antagonist, on the progression of thyroid eye disease
ea0101ps1-01-08
Anaplastic thyroid cancer
Estrogen-related receptor gamma (ERR[gamma]) as a therapeutic target for anaplastic thyroid cancer and the synergistic killing effect of DN200434 (ERR[gamma] inverse-agonist) and MK2206 (AKT inhibitor) in thyroid cancers
ea0101ps1-02-01
Thyroid fibrosarcoma as a rare differential diagnosis of anaplastic thyroid cancer: a case report
ea0101ps1-02-02
Low dose radiation can improve the therapeutic efficacy of immune checkpoint inhibitor in a mouse anaplastic thyroid cancer model
ea0101ps1-02-03
Progression of papillary thyroid carcinoma to anaplastic carcinoma in metastatic lymph nodes
ea0101ps1-02-04
Clinical and therapeutic particularities of anaplastic thyroid carcinoma
ea0101ps1-02-05
NF1 mutations in anaplastic thyroid cancer: from genetic insights to therapeutic potential
ea0101ps1-02-06
Evaluation of the antineoplastic effect of cabozantinib in primary human cell cultures from anaplastic thyroid carcinoma
ea0101ps1-02-07
Limited efficacy in adding lenvatinib for braf V600E-mutated anaplastic thyroid carcinoma (brafm-atc) progressing on braf-directed therapy
ea0101ps1-02-08
Clinical applicability of liquid biopsy for the management of anaplastic thyroid carcinoma (ATC), a monocentric experience
ea0101ps1-02-09
Liquid biopsy in the follow-up of a patient with braf positive anaplastic thyroid cancer and breast cancer
ea0101ps1-02-10
Thyoid cancer case reports-1
Refractory thyroid carcinoma treated by sorafenib
ea0101ps1-03-01
Two rare cases of benign struma ovarii with malignant recurrence
ea0101ps1-03-02
Rare thyroid gland tumors
ea0101ps1-03-03
Retropharyngeal node metastasis from papillary thyroid carcinoma
ea0101ps1-03-04
Embryo/Fetus dose from [131I]nai therapy during an unsuspected pregnancy
ea0101ps1-03-05
Subacute thyroiditis as the cause of a suspected thyroid nodule
ea0101ps1-03-06
Pregnancy and persistent distant metastases in differentiated thyroid cancer (DTC); a case report
ea0101ps1-03-07
Unusual locations of a pappilary thyroid microcarcinoma
ea0101ps1-03-08
Intrathyroidal parathyroid carcinoma: a case report
ea0101ps1-03-09
Medullary thyroid cancer-1
Comprehensive appearance of men 2a due to CYS634ARG mutation
ea0101ps1-04-01
Trends in the incidence, organization of care, and treatment of medullary thyroid cancer in the netherlands over the last three decades: a population-based study
ea0101ps1-04-02
The intratumoral infiltration of macrophages is associated with concomitant lymphocytic thyroiditis and possibly worse prognosis in patients with medullary thyroid carcinoma
ea0101ps1-04-03
Evidence for the founder effect of V804L and V804M pathogenic variants affected kindred of brazilian families spreading multiple endocrine neoplasia 2A (MEN2A)
ea0101ps1-04-04
Changing the paradigm: lobectomy for sporadic medullary thyroid cancer
ea0101ps1-04-05
C-Cells hyperplasia, what is their role in the development of sporadic medullary cancer?
ea0101ps1-04-06
Can haemithyroidectomy be an adequate treatment for nonhereditary medullary thyroid cancer (MTC)?
ea0101ps1-04-07
Medullary and papillary thyroid carcinoma presenting as a collision tumors in the thyroid: report of seven cases
ea0101ps1-04-08
Somatostatin analogues treatment in a patient suffering from a sporadic bifocal ret-negative medullary thyroid cancer with extended extrathyroidal spread after three surgical interventions
ea0101ps1-04-09
Clinical value of preoperative calcitonin for the prediction of distant metastases in patients with medullary thyroid carcinoma
ea0101ps1-04-10
Clinical thyroid cancer research-1
preexisting diabetes and aggressiveness of thyroid cancer: a cross sectional analysis
ea0101ps1-05-01
Serum anti-thyroglobulin antibody levels following total thyroidectomy are related to the recurrence of papillary thyroid carcinoma
ea0101ps1-05-02
Toxicity and quality of life after locoregional radiotherapy in patients with thyroid cancer
ea0101ps1-05-03
Reproductive concern and intention in young female patients with differentiated thyroid cancer after thyroidectomy: a prospective cohort study
ea0101ps1-05-04
Impact of lymph node metastases features on presentation and outcome of patients with differentiated thyroid carcinoma (DTC)
ea0101ps1-05-05
Data-driven thyroglobulin cutoffs for low- and intermediate-risk differentiated thyroid cancer follow-up in a real-world setting
ea0101ps1-05-06
Thyroidectomized patients on LT-4 therapy with advanced medullary thyroid carcinoma treated with selpercatinib show peculiar variations of thyroid function tests
ea0101ps1-05-07
Pediatric differentiated thyroid carcinoma: radioiodine treatment in hypothyroidism or after recombinant TSH?
ea0101ps1-05-08
Bone mineral density (BMD), bone turnover markers (BTMS) and evaluation of musculoskeletal system in patients with differentiated thyroid cancer undergoing TSH suppressive therapy
ea0101ps1-05-09
Differentiated thyroid carcinoma: preliminary results of a randomized clinical trial on the impact of transitioning care to primary healthcare supported by telemedicine
ea0101ps1-05-10
Thyroid cancer treatment
Intraoperative neuromonitoring does not decrease the risk of vocal cord palsy associated with thyroid cancer surgeries, but cumulative experience over time may
ea0101ps1-06-01
Impact of short lenvatinib interruptions in advanced thyroid cancer patients
ea0101ps1-06-02
Risk factors predicting papillary thyroid cancer recurrence: a single-surgeon experience
ea0101ps1-06-03
Radiofrequency ablation (RFA) for structural incomplete response (SIR) to therapy in differentiated thyroid cancer (DTC)
ea0101ps1-06-04
Counselling of thyroid cancer patients, what patient need to know from surgeon about treatment options, complications & follow-up
ea0101ps1-06-05
Molecular profile can influence the PFS in radioiodine-refractory thyroid cancer patients treated with lenvatinib
ea0101ps1-06-06
The role of primary non-selective laryngeal reinnervation in the treatment of invasive thyroid cancer
ea0101ps1-06-07
Can nocturnal administration of lenvatinib based on time pharmacology reduce adverse events?
ea0101ps1-06-08
Surgical management of medullary thyroid carcinoma with tracheal invasion
ea0101ps1-06-09
The risk of hypocalcemia in total thyroidectomy with comprehensive mediastinal-recurrent cellular and lymph-node dissection
ea0101ps1-06-10
Case reports
Intrathyroidal osseous metaplasia mimicking thyroid nodule suspicious for malignancy in a female patient with graves' disease- a case report
ea0101ps1-07-01
Liothyronine and a sudden unexplained death: cause or coincidence?
ea0101ps1-07-02
Methimazol-induced hepatitis in a patient with graves' disease
ea0101ps1-07-03
Combined immune checkpoint inhibitor therapy and onset of graves' hyperthyroidism followed by seroconversion to autoimmune hypothyroidism: a case report
ea0101ps1-07-04
Thyroid diagnostic dilemmas
ea0101ps1-07-05
Differential diagnostic challenges for ophthalmic diseases: a case report
ea0101ps1-07-06
Patient concurrent hashimoto thyroiditis, hypothyroidism and graves orbitopathy
ea0101ps1-07-07
Giant paracardial thyroid ectopy causing graves' hyperthyroidism. clinical and histological findings
ea0101ps1-07-08
A case of thyrotoxic periodical paralysis in a caucasian subject
ea0101ps1-07-09
Hyperthyroidism
Refractory case of amiodarone-induced thyrotoxicosis in a high cardiovascular risk patient
ea0101ps1-08-01
Prevalence of metabolic syndrome and its components in patients with controlled graves' disease
ea0101ps1-08-02
High frequency of mental fatigue after treatment of graves' hyperthyroidism but low rate of sick-leave - report from a longitudinal cohort in sweden
ea0101ps1-08-03
Thymic hyperplasia is accurate to detect new onset graves' hyperthyroidism and resolves after restoring euthyroidism
ea0101ps1-08-04
Trab levels and thyroid volume in graves' disease treated with block-replace therapy
versus
titration regimen
ea0101ps1-08-05
Healthcare professionals' experiences of caring for patients with graves disease- an interview study
ea0101ps1-08-06
Quality of life in graves disease: does type of treatment matter?
ea0101ps1-08-07
Contrast-enhanced ultrasound (CEUS) in hyperthyroid diffuse diseases
ea0101ps1-08-08
Quality of life after thyroidectomy for benign thyroid disease
ea0101ps1-08-09
Nodules
Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules smaller than 10 mm in the maximum diameter: the efficacy and its correlation with tirads classification
ea0101ps1-09-01
Acromegaly and thyroid nodules: a retrospective, single-centre, real-world observational study
ea0101ps1-09-02
Clinical utility of artificial intelligence in follow up of thyroid thermal ablative therapy for benign thyroid nodules
ea0101ps1-09-03
Application of shear wave elastography (SWE) in the management of thyroid nodules in children and adolescents
ea0101ps1-09-04
Predictive factors in patients rejected for radiofrequency ablation of cytologically benign thyroid nodules: an observational cohort study
ea0101ps1-09-05
Gender-based disparities in clinical presentation and outcomes of benign thyroid nodules
ea0101ps1-09-06
Active surveillance of bethesda iv nodules
ea0101ps1-09-07
Natural course of benign thyroid nodules
ea0101ps1-09-08
Role of elastography in the differentiation of thyroid
versus
parathyroid lesions
ea0101ps1-09-09
Changes of thyroid volume after iodine supplementation: preliminary data
ea0101ps1-09-10
Intracellular effects of TH
Type 3 deiodinase is a negative prognostic marker for hepatocarcinoma
ea0101ps2-10-01
Non-genomic effects of thyroid hormones on the breast cancer microenvironment
ea0101ps2-10-02
Thyroid hormone receptor [alpha] is involved in pro- and anti-inflammatory properties of murine macrophages
ea0101ps2-10-03
Unravelling the role of MCT8 in early brain development
ea0101ps2-10-04
Exploring the molecular mechanisms underlying radiation-induced thyroid damage using an organoid model
ea0101ps2-10-05
The role of thyroid hormone receptor A1 (TRA1) signaling in parvalbumin-expressing interneurons in the central regulation of the cardiovascular system and anxiety-like behavior
ea0101ps2-10-06
Brain abnormalities in young mice harboring combined NKX2-1 and PAX8 gene mutations
ea0101ps2-10-07
Regulation of hepatic mitochondrial quality control system by 3,5-diiodo-l-thyronine (3,5-t2) in a mouse model of high-fat diet-induced nafld
ea0101ps2-10-08
Exploring the role of DIO2 in the control of proliferation and cell fate determination in adult neural progenitors
ea0101ps2-10-09
Impact of triiodothyronine (T3) on differentiation and T3-responsive characteristics in ipsc-derived hepatocyte-like cells to study energy and lipid metabolism
ea0101ps2-10-10
Basic thyroid cancer research-1
Anti-proliferative and anti-migratory activity of licorice extract and glycyrrhetinic acid on papillary thyroid cancer cultures
ea0101ps2-11-01
Maldi-ms imaging in niftp diagnosis: an alternative approach
ea0101ps2-11-02
Generation of medullary thyroid cancer ex-vivo cellular models
ea0101ps2-11-03
Downregulation of MIR-346 affects the expression of nuclear receptor-interacting protein 1 (NRIP-1) and estrogen receptors in follicular thyroid cancer
ea0101ps2-11-04
Fusion partner agnostic approaches improve detection of targetable gene fusions in thyroid cancers
ea0101ps2-11-05
The autonomic system balance and integrin AVB related molecular markers in patients with papillary thyroid carcinoma
ea0101ps2-11-06
Effects of crizotinib in strn-alk anaplastic thyroid cancer in primary culture
in vitro
ea0101ps2-11-07
TSHR variants in benign and malignant thyroid tumors
ea0101ps2-11-08
Dual agonism of sodium iodide symporter function
in vivo
ea0101ps2-11-09
Exploring the genetic links between voltage-gated potassium channels and familial non-medullary thyroid carcinoma: a family study
ea0101ps2-11-10
Diagnosis of thyroid cancer-1
The clinical significance of markedly elevated preoperative serum thyroglobulin levels
ea0101ps2-12-01
Performance of eu-tirads, ATA and AACE/ACE-AME ultrasound risk stratification system (RSS) in pediatric patients with thyroid nodules
ea0101ps2-12-02
Differences and analogies in thyroid cancer discovered incidentally or by thyroid related screening: a multicenter study
ea0101ps2-12-03
Markers of aggressiveness in radioiodine-refractory thyroid cancer
ea0101ps2-12-04
Comparative analysis of thyroid cytopathology preparation: conventional smear, liquid-based preparation, and their combination
ea0101ps2-12-05
A comparative study between the old and the new version of a microrna and dna-based molecular classifier for indeterminate thyroid nodules in real-world samples
ea0101ps2-12-06
Molecular profiling of thyroid nodules: insights from the mir-thype full trial in brazilian patients
ea0101ps2-12-07
Appropriately positioned molecular testing for cytologically indeterminate thyroid nodules in an optimized thyroid nodule diagnostic pathway has incremental impact in addition to clinical assessment, cytology and ultrasound malignancy risk
ea0101ps2-12-08
A combined approach TI-RADS and ceus in detecting thyroid cancer
ea0101ps2-12-09
A multi-center study of malignancy risk stratification of indeterminate thyroid fine needle aspiration cytologies based on mirna expression
ea0101ps2-12-10
Medullary thyroid cancer-2
Clinical and molecular analysis of a MEN2A kindred harboring the rare RET variant p.ser904phe
ea0101ps2-13-01
Basal calcitonin needs the help of stimulation test for the diagnosis of sporadic medullary thyroid cancer (MTC) only in selected cases
ea0101ps2-13-02
Role of procalcitonin in unmasking false hypercalcitoninemia
ea0101ps2-13-03
Sporadic medullary thyroid carcinoma: about 17 cases
ea0101ps2-13-04
Molecular characterization of circulating tumor cells (CTCS) in sporadic medullary thyroid carcinoma (SPMTC) patients
ea0101ps2-13-05
The impact of preoperative calcitonin screening on the prognosis of patients with medullary thyroid cancer: a retrospective multicenter cohort study
ea0101ps2-13-06
Unraveling the prevalence and clinical behavior or sporadic apparently non-invasive medullary thyroid carcinoma
ea0101ps2-13-07
Usefulness of extensive germline ret testing in apparently sporadic medullary thyroid cancer
ea0101ps2-13-08
Index cases of familial medullary thyroid carcinoma show different clinical presentation and outcome compared to sporadic cases
ea0101ps2-13-09
Pathological and molecular characterization of peritumoral desmoplasia in medullary thyroid carcinoma
ea0101ps2-13-10
Clinical thyroid cancer research-2
High concordance in intuitive
vs
standardized assessment of whole-body scintigraphy after radioiodine therapy for thyroid cancer
ea0101ps2-14-01
Tracking dynamic evolution of low- and intermediate-risk differentiated thyroid cancer. identification of individuals at risk of recurrence
ea0101ps2-14-02
Impact of presence of psammoma bodies on long-term prognosis in papillary thyroid carcinoma cases
ea0101ps2-14-03
Subcutaneous neck metastases from thyroid cancer: a series of six cases diagnosed and followed-up in a single center
ea0101ps2-14-04
Real life experience of a single center in the treatment of metastatic rai refractory (RAI-R) differentiated thyroid carcinoma (DTC)
ea0101ps2-14-05
Postoperative basal serum thyroglobulin and need for radioiodine in patients with low to intermediate-risk papillary thyroid cancer
ea0101ps2-14-06
Differentiated thyroid cancer in children: a single institution experience of 7 years
ea0101ps2-14-07
Needle tract seeding of thyroid cancer after biopsy of distant metastasis: a retrospective cohort study
ea0101ps2-14-08
Predictive factors determining incomplete response to initial radioiodine therapy in patients with papillary thyroid microcarcinoma
ea0101ps2-14-09
Are we able to preoperatively predict low-risk thyroid cancer? a retrospective analysis of preoperative ultrasound in large group of patients
ea0101ps2-14-10
Translational thyroid cancer research-1
Development of a molecular quantum chemistry-based pipeline combined with publicly available datasets and robust open-source bioinformatics tools that indicate variations in redox balance genes that may have diagnostic and prognostic significance in thyroid cancer
ea0101ps2-15-01
Expression of HSA-MIR-139-5P as a clinically feasible prognostic marker for thyroid cancer
ea0101ps2-15-02
Genomic profiling of metastases from papillary and poorly differentiated thyroid carcinomas
ea0101ps2-15-03
Usefulness of metabolomic analyses in the pre surgical evaluation of thyroid nodules
ea0101ps2-15-04
BRAF mutation is associated with tumor volume doubling time of thyroid microcarcinoma during active surveillance
ea0101ps2-15-05
Methionyl-trna synthetase 1 expression as a diagnosis and prognosis factor in papillary thyroid cancer
ea0101ps2-15-06
Analysis of the impact of oncocytic cells on the performance of the thyroid molecular classifier based on micrornas and DNA: results from the optimized version of the MIR-thype test
ea0101ps2-15-07
How (respiratory) air can complement the diagnosis of thyroid changes - a pilot study using ion mobility spectrometry
ea0101ps2-15-08
Impact of genomic biomarkers on treatment decisions and clinical outcomes in patients with radioiodine-refractory thyroid cancer and treatment with multi-tyrosine kinase inhibitors - a multi-center registry analysis
ea0101ps2-15-09
Abstract withdrawn
ea0101ps2-15-10
Diagnostics and Populations Studies
A review on impediments related to the legislation and implementation regarding iodine deficiency disorders in pakistan; a lesson for other nations
ea0101ps2-16-01
Increased psychological distress among patients with thyroid diseases during COVID-19 pandemic: the epitome study
ea0101ps2-16-02
Management of central hypothyroidism in geriatric patient with panhypopituitarism due to pituitary apoplexy
ea0101ps2-16-03
Association of thyroid peroxidase antibodies and high-sensitivity c-reactive protein in men and women: a cross-sectional analysis from the elsa-brasil study
ea0101ps2-16-04
Nadh fluorescence in the skin is a novel biomarker of hypothyroidism-associated impairment of energy metabolism
ea0101ps2-16-05
Very low rates of thyroid function testing in human studies evaluating basal metabolic rate
ea0101ps2-16-06
Iodine intake and thyroid diseases in adult subject from different geographical regions of croatia
ea0101ps2-16-07
Acquired hypothyroidism, iodine status and hear impairment in adults
ea0101ps2-16-08
Thyroid function and incidence of increased carotid intima-media thickness: results from elsa-brasil cohort study
ea0101ps2-16-09
Diagnostic role of thyroid elastography in graves' disease
ea0101ps2-16-10
Non-surgical treatment
Predictive factors for success of radioactive iodine treatment in graves' disease
ea0101ps2-17-01
Efficacy of radioactive iodine treatment in graves' disease using a calculated 131i dose in a portuguese cohort
ea0101ps2-17-02
Abstract withdrawn
ea0101ps2-17-03
Efficacy of intrathyroidal dexamethasone injection in steroid-dependent subacute thyroiditis - preliminary report of dlisat study
ea0101ps2-17-04
J-131 therapy in patients with autonomously functioning thyroid nodules and normal FT4 blood level
ea0101ps2-17-05
Proficiency in performing radiofrequency ablation procedure for non-functioning benign thyroid nodules: a qualitative rather than quantitative matter
ea0101ps2-17-06
Abstract withdrawn
ea0101ps2-17-07
Laser thermal ablation for benign thyroid nodules: a single polish centre experience
ea0101ps2-17-08
Safety and efficacy of ultrasound-guided thrombin injection for pseudoaneurysms arising after ultrasound-guided biopsy of thyroid nodules
ea0101ps2-17-09
Prevalence and ultrasonography features of thyroglossal duct cyst in adults according to radioactive iodine ablation
ea0101ps2-17-10
Pregnancy
Changes of central sensitivity to thyroid hormones during pregnancy
ea0101ps2-18-01
Iodine status in pregnant women with hashimoto's thyroiditis: is iodine supplementation needed?
ea0101ps2-18-02
Thyroid function in pregnancy in normal weight and obese women without thyroid diseases
ea0101ps2-18-03
Mild & moderate iodine deficiency in pregnant women from sub-himalayan regions of india: impact on thyroid status
ea0101ps2-18-04
Trimester specific thyroid hormone reference range in mild iodine deficiency compared to normal iodine nutrition
ea0101ps2-18-05
Iodine status in a population-based cohort study of a multiethnic pregnant women in norway
ea0101ps2-18-06
An innovative method to better understand thyroid function changes: longitudinal trajectories of gestational thyroid function
ea0101ps2-18-07
Iodine availability from prenatal supplements in portugal
ea0101ps2-18-08
Maternal urinary iodine concentration and thyroid function in the offspring: preliminary results of an italian multicenter study
ea0101ps2-18-09
Thyroid and fertility: a survey on the clinical practice among endocrinologists belonging to the italian thyroid association (AIT)
ea0101ps2-18-10
TED
Analysis of thyroid stimulating immunoglobulins vs conventional TSH-receptor antibodies in clinical practice
ea0101ps2-19-01
In vivo
and
in vitro
evidence for a protective role of autoantibodies against the insulin-like growth factor-1 receptor (IGF-1R) in graves' orbitopathy
ea0101ps2-19-02
The association of the cholesterol metabolic profile and fatty acid content with the clinical phenotype of graves' orbitopathy
ea0101ps2-19-03
Analytical performance of a novel bioassay for blocking thyrotropin receptor antibodies
ea0101ps2-19-04
Lymphocytes' immunophenotype guided treatment in a thyroid eye disease patient successfully treated with rituximab
ea0101ps2-19-05
Graves orbitopathy, does all the patients evolve in the same way?
ea0101ps2-19-06
Duration of treatment for thyroid eye disease
ea0101ps2-19-07
Management of thyroid eye disease (TED) related strabismus in euthyroid patient with with negative anti thyroid antibodies
ea0101ps2-19-08
A marker of inflammatory state and the clinical outcome of active go to parenteral glucocorticoids
ea0101ps2-19-09
Abstract withdrawn
ea0101ps2-19-10
Thyroid function, feedback & disruptors
A new mouse model to better decipher the minimum proportion of active follicles required to sustain normal thyroid function
ea0101ps3-20-01
Overview of traditional chinese medicine for hashimoto's thyroiditis: focus on selenium and antioxidant phytochemicals
ea0101ps3-20-02
Variable sensitivity of thyroid hormone feedback in different zebrafish models of thyroid dysfunction
ea0101ps3-20-03
Identification of eukaryotic translation initiation factor 4b as a novel candidate gene for congenital hypothyroidism
ea0101ps3-20-04
Investigating the safety and NRF2 activation of a sulforaphane-generating supplement through drinking water in mice across thyroid and other tissues
ea0101ps3-20-05
Optimization of the spatial transcriptomics technology to explore the combined effect of a perinatal exposure to TBBPA and western diet at adult age on the unique transcriptomic signature of the different hypothalamic NUCLEI
ea0101ps3-20-06
Dissecting oxidation-dependent and oxidation-independent components of thyroid autoregulation
ea0101ps3-20-07
Exposure to an EDC mixture disrupts thyroid function in mice in a sex specific manner
ea0101ps3-20-08
Identification of markers for thyroid signaling disruption by transcriptomic analysis in teleost fish and amphibian
ea0101ps3-20-09
Thyoid cancer case reports-2
A rare thyroid cancer - case report of a follicular thyroid lymphoma
ea0101ps3-21-01
A case of bilateral chylothorax after a total thyroidectomy and left sided modified radical neck dissection for papillary thyroid cancer
ea0101ps3-21-02
Autonomous thyroid hormone production in metastatic follicular cancer - a case report
ea0101ps3-21-03
Papillary thyroid carcinoma arising within a mature ovarian cystic teratoma: a case report
ea0101ps3-21-04
Massive thrombosis of the internal jugular vein by a thyroid gland carcinoma
ea0101ps3-21-05
Metastasis to the thyroid gland: a rare etiology of thyroid nodules associated with malignant neoplasms
ea0101ps3-21-06
An innovative way of administration of radioactive iodine in an 11 years' old girl with intellectual disability after total thyroidectomy for differentiated thyroid cancer
ea0101ps3-21-07
Epidural metastases revealing differentiated thyroid cancer: a case report
ea0101ps3-21-08
Papillary thyroid cancer (PTC) Coexisting with thyroid tuberculosis: about cases
ea0101ps3-21-09
Atypical metastasis of follicular thyroid carcinoma
ea0101ps3-21-10
Diagnosis of thyroid cancer-2
Ultrasonographic features predicting lateral cervical lymph node metastases in patients with papillary thyroid microcarcinoma
ea0101ps3-22-01
Fine needle aspiration cytology in the diagnosis of thyroid nodules
ea0101ps3-22-02
Cost-effectiveness of diagnosis by ultrasound for asymptomatic thyroid cancer in south korea
ea0101ps3-22-03
The value of acr, european, korean and ATA ultrasound risk stratification systems combined with ras mutations for detecting thyroid carcinoma in cytologically indeterminate and suspicious for malignancy thyroid nodules
ea0101ps3-22-04
Efficacy of machine learning model in predicting thyroid malignancy risk
ea0101ps3-22-05
Diagnostic and prognostic roles of perioperative F18-FDG PET/CT for differentiated thyroid cancer
ea0101ps3-22-06
Predicting extrathyroidal extension (ETE) of differentiated thyroid carcinoma (DTC) preoperatively by using ultrasonography (US)
ea0101ps3-22-07
[18F]fluorocholine positron emission tomography/computed tomography characterization of hyperfunctioning and hypofunctioning benign thyroid nodules
ea0101ps3-22-08
Predictive value of quantitative indexes of FDG pet in the evaluation of thyroid nodules
ea0101ps3-22-09
Characteristics of bethesda 3 and 4 thyroid nodules: bethesda grey area
ea0101ps3-22-10
Complexities and challenges in the diagnosis and management of borderline thyroid tumors
ea0101ps3-22-11
Clinical thyroid cancer research-3
Real-life levothyroxine intake with possible restriction of absorption in thyroid cancer patients
ea0101ps3-23-01
Thyroid nodules in children
ea0101ps3-23-02
DICER1-associated thyroid tumour families
ea0101ps3-23-03
Distinguishing follicular-type thyroid carcinomas from their benign counterparts, a study of 104 consecutively resected and needle-biopsied tumors
ea0101ps3-23-04
Clinicopathological characteristics and outcome of patients with poorly differentiated thyroid cancer-a single center experience
ea0101ps3-23-05
Overweight as a risk factor for concomitant thyroid cancer in graves' disease patients: a retrospective study
ea0101ps3-23-06
Early detection and management of hypocalcaemia after total thyroidectomy
ea0101ps3-23-07
Association between diabetes mellitus and molecular profile in papillary thyroid carcinoma patients: a retrospective study
ea0101ps3-23-08
Thyroid cancer associated with hashimoto thyroidits : pronostic outcomes
ea0101ps3-23-09
Abstract withdrawn
ea0101ps3-23-10
Translational thyroid cancer research-2
HIF-1[alpha] inhibitors could successfully inhibit the progression of differentiated thyroid cancer
ea0101ps3-24-01
Non-genetic risk factors for thyroid cancer an umbrella review of evidence
ea0101ps3-24-02
Thyroid differentiation score (TDS) can differentiate between malignant and benign thyroid neoplasms
ea0101ps3-24-03
Comparison of mutational profiles between papillary thyroid microcarcinoma with central neck lymph nodes and without central neck lymph nodes
ea0101ps3-24-04
Potential influence of MIR-204-3P on ETS-1 protein expression in papillary thyroid carcinoma
ea0101ps3-24-05
Molecular profiling of advanced thyroid cancer: characterizing tumors for targeted treatment
ea0101ps3-24-06
DNA methylation in the thyroid tumors with known gene alteration
ea0101ps3-24-07
No responsiveness of the thyroid to protective effects of melatonin against chromium-induced oxidative damage - comparison to the ovary and non-endocrine tissues
ea0101ps3-24-08
Use of liquid biopsy in metastatic differentiated thyroid cancer: paving the way of precision management
ea0101ps3-24-09
Association between single nucleotide polymorphisms and disease aggressiveness in patients with papillary thyroid cancer. do we have a new diagnostic tool?
ea0101ps3-24-10
Hypothyroidism
Understanding levothyroxine dosage adjustments after bariatric surgery
ea0101ps3-25-01
A national randomized placebo-controlled double-blind multicenter trial of LT4/lT3 combination therapy in patients with autoimmune hypothyroidism: T3-4-hypo trial
ea0101ps3-25-02
Rapid levothyroxine absorption test: results in 143 refractory hypothyroid patients treated with oral levothyroxine
ea0101ps3-25-03
Riedel's thyroiditis: report of 7 patients
ea0101ps3-25-04
Autoimmune hypothyroidism incidence in a large population-based study in northeastern italy
ea0101ps3-25-05
Breakfast habits in patients using levothyroxine: a questionnaire survey on patient experiences and preferences
ea0101ps3-25-06
Effect of bariatric surgery on tsh levels and levothyroxine dosage in patients with thyroid disease: sleeve gastrectomy vs roux-en-y gastric bypass
ea0101ps3-25-07
Circulating tsh levels are more stable in patients with hypothyroidism treated with liquid L-T4
ea0101ps3-25-08
Potential risks and benefits of desiccated thyroid extract for the treatment of hypothyroidism: a systematic review
ea0101ps3-25-09
Rebound effect in hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism and hormonal replacement therapies
ea0101ps3-25-10
Miscellaneous
Parathyroid adenoma : radiologic features and correlation study with
99m
Tc-sestamibi spect findings
ea0101ps3-26-01
Calcitonin levels and pseudohypoparathyroidism: understanding the connection
ea0101ps3-26-02
Thyrolipoma and thyrolipmatosis
ea0101ps3-26-03
Association between thyroid function and periodontitis
ea0101ps3-26-04
Evaluation of topical hemostatic agents (THA) used in perioperative period in thyroidectomy patients: assessment of ultrasonographic characteristics, resolution durations, and potential long-term complications
ea0101ps3-26-05
Obesity related hypoventilation syndrome in patients with hypothyroidism
ea0101ps3-26-06
Thyroid and Genetics
Identification of a stat3 mutation, P.THR716MET in two cases of very early-onset autoimmune hypothyroidism
ea0101ps3-27-01
New insights in the diagnosis and treatment of allan-herndon-dudley syndrome
ea0101ps3-27-02
Thyroid hormone resistance in an infant harboring a novel
de novo
mutation of the thrb gene
ea0101ps3-27-03
The whole-genome DNA methylation pattern in peripheral white blood cells in adults and children with graves' disease
ea0101ps3-27-04
Thyroid hormone analogue (TRIAC) therapy in resistance to thyroid hormone beta, reduces hyperthyroid symptoms, lowers circulating thyroid hormones and metabolic rate effectively, without adverse effects
ea0101ps3-27-05
Decoding SLC26A7'S role in congenital hypothyroidism: delayed onset, very large goiters, and thyrotropin dependent basolateral expression
ea0101ps3-27-06
The incidence of multinodular goiter in patients with DICER1 syndrome and the risk of cancer
ea0101ps3-27-07
Unique features of resistance to thyroid hormone alpha due to a homozygous mutation in thra
ea0101ps3-27-08
Intergenerational anticipation of disease onset in families with autoimmune thyroid disease
ea0101ps3-27-09
Treatment – surgery
clinical impact of pectoral nerve ii block on postoperative pain, opioid usage, and patient recovery experience in robot-assisted transaxillary thyroidectomy: a prospective, randomized controlled trial
ea0101ps3-28-01
Total thyroidectomy and quality of life in patients with hashimoto thyroiditis, a scoping review
ea0101ps3-28-02
Pre-thyroidectomy vitamin d&calcium administration to prevent hypocalcemia: a systematic review
ea0101ps3-28-03
Establishing transoral thyroid and parathyroid endoscopic vestibular approach (toetva-toepva) service in the united kingdom national health system: the safe road to success
ea0101ps3-28-04
Comparison of voice outcome according to the degree of thyroidectomy
ea0101ps3-28-05
Emergency surgery for post-thyroidectomy hematoma: a life saving procedure
ea0101ps3-28-06
Thyroid operation under local anesthesia in bangladesh, how & when i do
ea0101ps3-28-07
Robotic transaxillary surgery -a scarless safe option for thyroid surgery
ea0101ps3-28-08
A short course of lugol's solution in toxic nodular thyroid disease: a pre-post intervention study on thyroid hormones and quality of life
ea0101ps3-28-09
Extent of surgery in the surgical treatment of graves' disease: subtotal vs. total thyroidectomy and comparison of the long-term results
ea0101ps3-28-10